Patients with generalized pustular psoriasis experience frequent flares; treatment alterations of off-label agents are frequently observed.

Patients with generalized pustular psoriasis continued to experience frequent flares that were often uncontrolled by ...

Icotrokinra appears to be an effective treatment for adolescents with moderate to severe plaque psoriasis, according to a subgroup analysis of the ICONIC-LEAD study.

There is higher risk for cardiovascular complications during delivery in pregnant patients with psoriasis compared with patients without psoriasis.

New results from a subgroup analysis of the ICONIC-LEAD study showed icotrokinra was effective and safe for the treatment of moderate to severe plaque psoriasis in adolescents, according to a press ...

Stress, extreme temperatures, and infectious illnesses can all trigger flares of scalp psoriasis. In the United States, more than 8 million people are living with psoriasis. Psoriasis frequently ...

Deucravacitinib has been observed as a safe and efficacious treatment for adults with moderate to severe plaque psoriasis for up to 4 years.

A panelist discusses how real-world evidence from a large cohort study (n = 31521) presented at AAD 2025 reveals notable ...

Icotrokinra is efficacious and safe for treating moderate to severe plaque psoriasis among adolescents and adults when compared with placebo.